These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16280658)

  • 1. Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms: a tissue microarray study of 1,754 cases.
    Kambham N; Kong C; Longacre TA; Natkunam Y
    Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):304-10. PubMed ID: 16280658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
    Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
    Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms.
    O'Connell FP; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2004 Feb; 121(2):254-63. PubMed ID: 14983940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas.
    Saqi A; Yun SS; Yu GH; Alexis D; Taub RN; Powell CA; Borczuk AC
    Diagn Cytopathol; 2005 Aug; 33(2):65-70. PubMed ID: 16007640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of syndecan-1 in prostate cancer.
    Kiviniemi J; Kallajoki M; Kujala I; Matikainen MT; Alanen K; Jalkanen M; Salmivirta M
    APMIS; 2004 Feb; 112(2):89-97. PubMed ID: 15056224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer.
    Wiksten JP; Lundin J; Nordling S; Lundin M; Kokkola A; von Boguslawski K; Haglund C
    Int J Cancer; 2001 Jan; 95(1):1-6. PubMed ID: 11241302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.
    Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Takamori K; Igawa K; Yoshida M; Fukuyama H; Takahashi T; Sakoda S
    J Oral Pathol Med; 2006 May; 35(5):301-6. PubMed ID: 16630294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
    Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
    Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.
    Kind S; Jaretzke A; Büscheck F; Möller K; Dum D; Höflmayer D; Hinsch A; Weidemann S; Fraune C; Möller-Koop C; Hube-Magg C; Simon R; Wilczak W; Lebok P; Witzel I; Müller V; Schmalfeldt B; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Krech T; Krech RH; von der Assen A; Bawahab AA; Burandt E
    Mol Carcinog; 2019 Dec; 58(12):2306-2315. PubMed ID: 31545001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
    Rintala M; Inki P; Klemi P; Jalkanen M; Grénman S
    Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of syndecan-1 expression in ductal carcinoma in situ of the breast.
    Tiemann K; Weigel MT; Alkatout I; Wenners AS; Mundhenke H; Schäfer FW; Bauer M; Schem C; Maass N; Jonat W; Mundhenke C
    Anticancer Res; 2014 Jul; 34(7):3607-16. PubMed ID: 24982376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
    Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
    Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry.
    Natkunam Y; Warnke RA; Montgomery K; Falini B; van De Rijn M
    Mod Pathol; 2001 Jul; 14(7):686-94. PubMed ID: 11455001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of syndecan-1 expression is associated with dysplastic oral epithelium.
    Soukka T; Pohjola J; Inki P; Happonen RP
    J Oral Pathol Med; 2000 Aug; 29(7):308-13. PubMed ID: 10947246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies.
    Chilosi M; Adami F; Lestani M; Montagna L; Cimarosto L; Semenzato G; Pizzolo G; Menestrina F
    Mod Pathol; 1999 Dec; 12(12):1101-6. PubMed ID: 10619261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
    Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
    Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
    Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
    Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma.
    Stanley MJ; Stanley MW; Sanderson RD; Zera R
    Am J Clin Pathol; 1999 Sep; 112(3):377-83. PubMed ID: 10478144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan-1 expression--a novel prognostic marker in pancreatic cancer.
    Juuti A; Nordling S; Lundin J; Louhimo J; Haglund C
    Oncology; 2005; 68(2-3):97-106. PubMed ID: 15886501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers.
    Conejo JR; Kleeff J; Koliopanos A; Matsuda K; Zhu ZW; Goecke H; Bicheng N; Zimmermann A; Korc M; Friess H; Büchler MW
    Int J Cancer; 2000 Oct; 88(1):12-20. PubMed ID: 10962434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.